Triple 000 and Sub-penny Chart Plays

[trader53]

MNZO - Targets 0.0045


* Lactose intolerance shareholders looking for Big Runs!

Contact Info
PO Box 107
Milford, PA 18337

Website: http://manzopharma.com
Phone: [phone]
Email: [e-mail]


Targets 0.0045
http://www.allotcbb.com/quote.php?symbol=mnzo

Share Structure
Market Value1.........$466,225 a/o Nov 18, 2014
Authorized Shares..950,000,000 a/o Sep 29, 2014
Shares Outstanding 388,521,167 a/o Sep 29, 2014
Float..............329,885,864 a/o Sep 29, 2014
Par Value 0.001

http://www.otcmarkets.com/stock/MNZO/profile

Nov 17, 2014
Quarterly Report
http://www.otcmarkets.com/stock/MNZO/filings


Nov. 12, 2014
Manzo Pharmaceuticals
begins retail distribution of products
with independent pharmacies
http://finance.yahoo.com/news/manzo-pharmaceuticals-begins-retail-distribution-150000537.html

http://www.allotcbb.com/quote.php?symbol=mnzo

http://stockcharts.com/h-sc/ui?s=MNZO&p=D&yr=1&mn=1&dy=0&id=p60340644392







Manzo Pharmaceuticals, Inc.

* a strategy for releasing current development to the public is being put together and shareholders should expect many developments in the very near future.

* On top of the list is the company's patent pending probiotic for people who suffer from lactose intolerance but many other products, partnerships, and developments have been being worked on over the past two months.

* The new technology that enables the probiotic to curb lactose intolerance symptoms has many applications, putting Manzo Pharmaceuticals in the position of developing and licensing that technology creating solutions that could put the company on the map.


About Manzo Pharmaceuticals, Inc.

Manzo Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the research, development,
and testing of patented and non-patented solutions and remedies.

Most notably is a patented solution for lactose Intolerance,
and a natural remedy for colic in babies.

For more information follow the company on twitter
at @manzopharma,
and visit
www.manzopharma.com